Precision risk-based screening might maximize benefit and minimize harm

Nat Rev Clin Oncol. 2018 Nov;15(11):661-662. doi: 10.1038/s41571-018-0093-0.
No abstract available

Publication types

  • Comment

MeSH terms

  • Breast Neoplasms*
  • Cost-Benefit Analysis
  • Early Detection of Cancer*
  • Humans
  • Mass Screening